After radiation therapy, certain cancer patients face a lingering question: Is a troubling lesion a return of the cancer, or ...

Elekta announced today that its Evo CT Linac received FDA 510(k) clearance, making it available to U.S. radiation oncology ...

The early-stage clinical trial marks the first U.S. testing of Alveltamig, an immunotherapy designed to help the immune ...

Despite a decade cancer-free, a new breast cancer diagnosis led to a bilateral mastectomy and later chemotherapy and ...

For a boy named after the Stanley Cup hockey championship trophy who learned to ice skate in preschool, playing hockey was ...

Cervical lymphadenopathy presents a shared anatomic challenge for clinicians, yet it serves as the divergent starting point ...

Rory Aroa, a 33-year-old father of two young children, died from melanoma after the cancer returned and spread aggressively, ...

This year, JPM 2026 took place again in San Francisco. Let’s look at predictions and trends forecast for 2026, according to ...

Dana Friesen, CEO of Summit Sciences, brings over 15 years of experience in financial analysis and ROI optimization within the medical device sector. The firm has delivered billions in lifetime ...

Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have opened a clinical trial that will look at whether ...

A multitargeted T-cell therapy produced encouraging activity in a preliminary study of patients with pancreatic cancer, ...

Baptist Hospital's new cancer center in Southeast Texas offers advanced HyperArc radiation technology, drastically cutting ...